References
- Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 2008; 49: 480-508. doi: 10.2967/jnumed.107.047787
- Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999; 19: 61-77; quiz 150-1. doi: 10.1148/radiographics.19.1.g99ja0761
- Rosenbaum SJ, Lind T, Antoch G, Bockisch A. False-positive FDG PET uptake-the role of PET/CT. Eur Radiol 2006; 16: 1054-65. doi: 10.1007/s00330-005-0088-y
- Israel O, Yefremov N, Bar-Shalom R, Kagana O, Frenkel A, Keidar Z, et al. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med 2005; 46: 758-62.
- Lerman H, Metser U, Grisaru D, Fishman A, Lievshitz G, Even-Sapir E. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and post-menopausal patients: assessment by PET/CT. J Nucl Med 2004; 45: 266-71.
- Liu Y. Benign ovarian and endometrial uptake on FDG PET-CT: patterns and pitfalls. Ann Nucl Med 2009; 23: 107-12. doi: 10.1007/s12149-008-0227-z
- Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996; 26: 308-14. doi: 10.1016/S0001-2998(96)80006-7
- Nishizawa S, Inubushi M, Okada H. Physiological 18F-FDG uptake in the ovaries and uterus of healthy female volunteers. Eur J Nucl Med Mol Imaging 2005; 32: 549-56. doi: 10.1007/s00259-004-1703-x
- Kim SK, Kang KW, Roh JW, Sim JS, Lee ES, Park SY. Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstrual cycle. Eur J Nucl Med Mol Imaging 2005; 32: 757-63. doi: 10.1007/s00259-005-1771-6
- Chiazze L, Jr., Brayer FT, Macisco JJ, Jr., Parker MP, Duffy BJ. The length and variability of the human menstrual cycle. JAMA 1968; 203: 377-80. doi: 10.1001/jama.1968.03140060001001
- Weir I. Spearman’s correlation. Statstutor, Mathematics Education Centre Loughborough University. 2016; 29. Available at: http://wwwstatstutoracuk/resources/uploaded/spearmanspdfAccessed.
- Csapo AI, Pinto-Dantas CA. The effect of progesterone on the human uterus. Proc Natl Acad Sci U S A 1965; 54: 1069-76. doi: 10.1073/pnas.54.4.1069
- Widmaier EP, Raff H, Strang KT. Vander’s human physiology: the mechanisms of body functions. New York: McGraw-Hill Higher Education; 2008.
- De Geyter C, De Geyter M, Huber PR, Nieschlag E, Holzgreve W. Progesterone serum levels during the follicular phase of the menstrual cycle originate from the crosstalk between the ovaries and the adrenal cortex. Hum Reprod 2002; 17: 933-9. doi: 10.1093/humrep/17.4.933
- Van Iten B. Estrogen and the Menstrual Cycle in Humans. Embryo Project Encyclopedia 2016. Available at: https://embryo.asu.edu/pages/estrogen-and-menstrual-cycle-humans
- Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev 2009; 30: 465-93. doi: 10.1210/er.2009-0006
- Kol S, Ben-Shlomo I, Ruutiainen K, Ando M, Davies-Hill TM, Rohan RM, et al. The midcycle increase in ovarian glucose uptake is associated with enhanced expression of glucose transporter 3. Possible role for interleukin-1, a putative intermediary in the ovulatory process. J Clin Invest 1997; 99: 2274-83. doi: 10.1172/JCI119403
- Balsara G, Hernandez E. The ovary: normal, physiologic changes, endometriosis, and metastatic tumors. Clinical Gynecologic Pathology. Philadelphia, PA: Saunders. 1995; 404-9.
- Reed BG, Carr BR. The normal menstrual cycle and the control of ovulation. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, et al, editors. Endotext [Internet] South Dartmouth (MA): MDText.com Inc.; 2000.
- Zhu Z, Wang B, Cheng W, Cheng X, Cui R, Huo L, et al. Endometrial and ovarian F-18 FDG uptake in serial PET studies and the value of delayed imaging for differentiation. Clin Nucl Med 2006; 31: 781-7. doi: 10.1097/01. rlu.0000247261.82757.ea